Study Analyzing Effectiveness of BIomarker for Immunosuppression Following Induction Immunosuppression for Lung Transplantation.

Overview

About this study

The purpose of this study is to longitudinally follow Torque Teno Virus (TTV) levels in lung transplant recipients and attempt to find a correlation with infection or rejection events.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

Patients undergoing lung transplantation at Mayo Clinic Florida.
Patients who receive induction immunosuppression with either Alemtuzumab or Thymoglobulin.

Exclusion Criteria:

Patients who do not receive induction therapy after lung transplantation.

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location	Status
Jacksonville, Fla. Mayo Clinic principal investigator Tathagat Narula, M.B.B.S., M.D.	Closed for enrollment

Mayo Clinic Location

Status

Jacksonville, Fla.

Mayo Clinic principal investigator

Tathagat Narula, M.B.B.S., M.D.

Closed for enrollment

More information

Publications

Publications are currently not available

Clinical Trials